Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation?

The aim of this prospective randomized study was to determine whether additional doxorubicin chemotherapy improves outcome in patients with hepatocellular carcinoma (HCCA) treated by liver transplantation. Stratification parameters were tumor stage (UICC I-IVa), gender, age 50 years, α-fetoprotein 20 ng/mL, cirrhosis and HbsAg status. For pre-operative chemotherapy doxorubicin (15 mg/m²) was given biweekly, intra-operative chemotherapy was a single dose administered before surgical manipulation. Post-operative chemotherapy from day 10 was as given preoperatively for a total dosage of 300 mg/m². Outcome parameters were overall survival (OS) and disease-free survival. Of the 75 consecutive patients who received liver transplantation for treatment of HCCA, 62 patients were enrolled. Thirty-four patients were randomized in the chemotherapy group; 28 patients were in the control group and transplanted only. OS rates at 5 years were 38% in the chemotherapy group and 40% in the control group, disease-free survival rates at 5 years 43% and 53%, respectively. Tumor stage and vascular invasion were identified as independent risk factors for recurrence of disease. Doxorubicin chemotherapy did not improve organ survival and disease-free survival in patients undergoing liver transplantation for HCCA.     

Validierung des NACA-Score anhand objektivierbarer Parameter

Zusammenfassung In einer retrospektiven Studie mit Daten aus 104.962 Primäreinsätzen von 28 Luftrettungszentren der ADAC-Luftrettung und des Bundesinnenministeriums vom 01.01.1999 bis 31.12.2003 wurde die Validität des präklinisch erhobenen NACA-Scores untersucht. Zur Klassifikation der Vitalfunktionen wurde der physiologisch orientierte, für die präklinische Patientenversorgung konzipierte MEES als Score genutzt. Für die Beurteilung der Notfallschwere war der kritischste Messwert für die jeweilige Vitalfunktion aus der präklinischen Versorgungsphase maßgebend. Die Ergebnisse zeigen, dass pathologische Messparameter der Vitalfunktionen für die Einordnung im NACA-Score durch den Notarzt in z. T. mehr als der Hälfte der Fälle keine Berücksichtigung finden. Selbst eindeutige Verläufe wie eine Reanimation oder der Tod des Patienten werden nicht korrekt klassifiziert. Auch unbestritten vitalbedrohende Krankheitsbilder wie der akute Myokardinfarkt (Fehleinschätzung: 51,5%), die Lungenembolie (40,1%) oder das Polytrauma (22,5%) werden im NACA-Score nicht als vitalbedrohend (mindestens NACA-Stufe V) eingeordnet. Zusammenfassend muss festgestellt werden, dass in Übereinstimmung mit der Literatur die Einordnung der Notfallschwere im NACA-Score durch den Notarzt stark subjektiven Einflüssen unterliegt. Daraus ergibt sich, dass der NACA-Score für wissenschaftliche Fragestellungen, zur Qualitätskontrolle und zur retrograden Beurteilung der Einsatzindikation allein ungeeignet ist. Es sollte ein modifizierter NACA-Score erarbeitet werden, der sich auf objektive Messwerte stützt.     

Experimental and clinical possibilities of MR spectroscopy of the heart

MR-spectroscopy of the heart is a relatively new technique for the study of various aspects of cardiac metabolism. The majority of results has so far been obtained with the isolated perfused heart. Here, 31P-MR spectroscopy can be employed to measure high-energy phosphate metabolism and intracellular pH repeatedly and non-invasively. Using a technique called saturation transfer, velocities of enzymatic reactions, such as the creatine kinase reaction, can be measured. Intra- and extracellular Na+ and K+ concentrations can be registered with 23Na- and 39K-MR in conjunction with shift reagent. 13C-MR can be used to tackle carbohydrate metabolism. In-situ-R-spectroscopy allows determination of high-energy phosphates in intact large mammals. Clinical applications of MR-spectroscopy remain to be defined; preliminary results indicate high diagnostic and prognostic potential for patients with coronary artery disease and congestive heart failure.     

Multimodale Behandlung einer Alopecia universalis

Alopecia universalis is characterized by total loss of body hair and can occur at any age, causing significant psychological morbidity in most cases. Though there is evidence to suggest that alopecia universalis is an autoimmune disease, the cause of the disease is still not known with certainty. Spontaneous recovery is unusual (<10%), and the long-term prognosis in cases not responding to therapy is poor, despite the variety of therapies available. Experience of immunosuppressive treatment in children with alopecia universalis is limited. We report on a 4-year-old boy, who was successfully treated for refractory alopecia universalis with prednisolone and cyclosporine A by mouth combined with topical application of tacrolimus. Our case report shows that systemic immunosuppression may be a promising treatment option for some children with alopecia universalis who are badly distressed by their condition. However, potential treatment-related risks have to be weighed against the psychosocial stress experienced by these patients and their families.     

Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI

In previous papers relative signal intensity increase was used as a quantitative assessment parameter for contrast uptake in contrastenhanced MRI. However, relative signal intensity increase does not only reflect contrast uptake but depends also on tissue parameters (native T₁ relaxation time) and sequence parameters (repetition time and flip angle); thus, the contrast uptake cannot be assessed accurately using relative signal intensity increase. Based on an analysis of the contrast behavior of spoiled gradient echo sequences, a method is described in this paper that overcomes the limitations of relative signal intensity increase measurement. A parameter, called “enhancement factor” (EF) is introduced that approximates differential T₁ relaxation rate. The enhancement factor scales linearly with contrast uptake and is independent of tissue and sequence parameters. The additional measurement time involved in determining the enhancement factor is less than 1 min and computation is straightforward. The practicality of the new method was confirmed by phantom measurements using T₁-weighted and proton density-weighted spoiled gradient echo sequences (FLASH-2D). Enhancing tissues were simulated by water phantoms doped with increasing concentrations of Gd-DTPA.     

„Scalping“

An 18-month-old boy was brought to hospital because of massive swelling and extensive haematoma of the forehead and eyelids. At first the mother reported that the child had fallen from his tricycle. Cranial computed tomographyy revealed an extensive subgaleal haematoma but bony injuries were not found. The results of police investigations revealed that the mother had locked the child’s head firmly between her arm and chest and jerked it backwards and forwards several times. The mother was convicted of child abuse.